Library

Protocol

GHRP-6 (2mg Vial)

Complete dosage protocol and reconstitution guide for GHRP-6 (2mg Vial).

Updated November 26, 2025 Research guide Research information only
Open calculator preset Build protocol outline TNHL options
Educational reference only. TNHL calculates and organizes user-entered values; it does not diagnose, prescribe, recommend doses, or replace guidance from a qualified professional.
MechanismGHRP-6 (Growth Hormone-Releasing Peptide 6) is a synthetic hexapeptide that functions as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a) [1] [2] . It stimulates pulsatile GH release from the pituitary gland while maintaining physiological feedback controls, resulting in elevated IGF-1 levels and potential anabolic benefits [3] .
Dosing300–900 mcg total (split into 3 doses with gradual titration).
ReconstitutionAdd 3.0 mL diluent to a 2 mg vial.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 7 days.

Calculator preset

Run the vial math before tracking.

At ~0.67 mg/mL, 1 unit ~ 6.7 mcg ; 100 mcg ~ 15 units and 300 mcg ~ 45 units on a U-100 syringe.

Calculate this vial

01 · At a glance

Quickstart Highlights

GHRP-6 (Growth Hormone-Releasing Peptide 6) is a synthetic hexapeptide that functions as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a) [1] [2] . It stimulates pulsatile GH release from the pituitary gland while maintaining physiological feedback controls, resulting in elevated IGF-1 levels and potential anabolic benefits [3] . This educational protocol presents a three-times-daily subcutaneous approach using practical dilution for precise insulin-syringe measurements.

ReconstituteAdd 3.0 mL bacteriostatic water → ~ 0.67 mg/mL concentration.
Reference dose300–900 mcg total (split into 3 doses with gradual titration).
Easy measuringAt ~0.67 mg/mL, 1 unit ~ 6.7 mcg ; 100 mcg ~ 15 units and 300 mcg ~ 45 units on a U-100 syringe.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 7 days.
Start with sterile preparation, storage, and injection-site basics before using any calculator output. TNHL is a tracking and education tool only.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3 mL = ~0.67 mg/mL)

Phase / setup Dose & frequency Volume / units
Weeks 1–2100 mcg15 units (0.15 mL)
Weeks 3–4200 mcg30 units (0.30 mL)
Weeks 5–12300 mcg45 units (0.45 mL)

300–900 mcg total (split into 3 doses with gradual titration).

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall to avoid foaming; do not shake.
  3. Gently swirl or roll the vial until the powder is completely dissolved.
  4. Label with date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
  5. Use within 7 days of reconstitution for optimal potency.

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Peptide vial 2 mg
  • Match the label on the vial before calculating.
Diluent 3.0 mL
  • Use only the diluent appropriate for the compound and instructions.
Syringes U-100 or custom
  • Calculator output can be translated to syringe units.
Tracking Protocol Pal
  • Log dose dates, inventory, sites, and observations.

Protocol Overview

  • Goal: Stimulate pulsatile GH release to support muscle growth, fat loss, and recovery [2] [7] .
  • Schedule: Three subcutaneous injections daily for 8–12 weeks, spaced at least 4 hours apart.
  • Dose Range: 100–300 mcg per injection with gradual titration (300–900 mcg total daily).
  • Reconstitution: 3.0 mL per 2 mg vial (~0.67 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated; use within 7 days.

Dosing Protocol

  • 300–900 mcg total (split into 3 doses with gradual titration).
  • Inject three times daily subcutaneously, spaced at least 4 hours apart (morning, midday, bedtime). GHRP-6 has a short half-life of approximately 2.5 hours [4] , making multiple daily injections more effective than once-daily dosing for sustained GH elevation [5] . Each injection should be administered on an empty stomach (2–3 hours after meals, 30 minutes before eating) to maximize GH release [6] .
  • If values change, rerun the calculator and update the protocol so future logs match the active plan.

Storage Instructions

  • Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 7 days.
  • Storage: Lyophilized frozen; reconstituted refrigerated; use within 7 days.
  • Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

  • Practical considerations for consistency and safety.
  • Use new sterile insulin syringes for each injection; dispose in a sharps container [9] .
  • Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce lipohypertrophy and local irritation [10] .
  • Inject slowly and wait a few seconds before withdrawing the needle.
  • GHRP-6 may increase appetite in some users due to its ghrelin-mimicking properties [11] .
  • Document daily doses, timing, and sites to maintain consistency throughout the cycle.

05 · How it works

How This Works

GHRP-6 (Growth Hormone-Releasing Peptide 6) is a synthetic hexapeptide that functions as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a) [1] [2] .

It stimulates pulsatile GH release from the pituitary gland while maintaining physiological feedback controls, resulting in elevated IGF-1 levels and potential anabolic benefits [3] .

This educational protocol presents a three-times-daily subcutaneous approach using practical dilution for precise insulin-syringe measurements.

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

  • Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
  • Track body metrics only if they are relevant to the user's goal and approved data sources.
  • Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

  • GHRP-6 observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
  • This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

Pre-injection preparation
  • Wash hands with soap and water.
  • Wipe the vial stopper and chosen site with alcohol, then let both dry.
  • Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
Injection procedure
  • Use the route and needle technique directed by a qualified professional or product instructions.
  • For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
  • Do not reuse needles or syringes.
Post-injection care
  • Dispose of sharps in a puncture-resistant container.
  • Return stored items promptly to the correct temperature.
  • Log dose, site, date, time, inventory change, and any observation.

09 · Evidence

References

TNHL options

Peptide collections stay passive.

Open the TNHL Stan Store option that fits the order size. Product details, checkout, and fulfillment stay off-site.

Related pages

Keep researching